Blackhawk Capital Partners Llc. Amgen Inc Transaction History

Blackhawk Capital Partners Llc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 04, 2020	SELL	$197.81 - $242.74 $1.18 Million - $1.45 Million	-5,987 Closed	0 $0
Q1 2020 Apr 03, 2020	SELL	$182.24 - $241.7 $50,116 - $66,467	-275 Reduced 4.39%	5,987 $1.44 Million
Q4 2019 Feb 07, 2020	BUY	$189.21 - $243.2 $6,433 - $8,268	34 Added 0.55%	6,262 $1.21 Million
Q3 2019 Nov 08, 2019	SELL	$174.11 - $208.62 $1,392 - $1,668	-8 Reduced 0.13%	6,228 $1.21 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $121,024 - $141,867	726 Added 13.18%	6,236 $1.15 Million
Q1 2019 May 08, 2019	BUY	$180.87 - $203.88 $81,753 - $92,153	452 Added 8.94%	5,510 $1.05 Million
Q4 2018 Feb 04, 2019	SELL	$178.4 - $208.25 $32,825 - $38,318	-184 Reduced 3.51%	5,058 $985,000
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $29,461 - $33,213	-159 Reduced 2.94%	5,242 $1.09 Million
Q2 2018 Aug 09, 2018	SELL	$166.05 - $186.51 $92,988 - $104,445	-560 Reduced 9.39%	5,401 $997,000
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $35,241 - $41,184	-208 Reduced 3.37%	5,961 $1.02 Million
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $1.04 Million - $1.16 Million	6,169	6,169 $1.07 Million

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Blackhawk Capital Partners Llc., based on Form 13F filings with the SEC.

Stay updated on Blackhawk Capital Partners Llc. with notifications on news.